This reference uses the specific documents linked in the article and listed below. Check their scope, publication dates and the statements they support.
The name describes milk loss, but the syndrome reaches beyond the udder
An affected lactating ewe or doe may produce less milk or abnormal milk and have a painful udder. Other animals in the same group may show lameness from joint disease or painful, cloudy eyes. Young animals can develop more severe illness, including respiratory or systemic disease in some outbreaks. Clinical range of contagious agalactia.
Do not wait for the complete textbook combination of mastitis, arthritis and keratoconjunctivitis in one animal. A flock pattern may be distributed across several animals, and one manifestation may dominate. Conversely, ordinary mastitis or a single lame animal is not enough to diagnose this syndrome.
The consequences extend to offspring. A dam’s loss of milk can leave lambs or kids hungry even before the mother looks severely ill. Assess nursing young directly: are they vigorous, gaining and obtaining milk, or repeatedly seeking a feed they cannot get?
Which mycoplasma is involved matters
Mycoplasma agalactiae is the main cause in sheep and goats. Other mycoplasmas can produce a similar syndrome, particularly in goats, and some presentations include pneumonia. They are not all the same organism or the same clinical problem. WOAH’s organism and syndrome distinctions.
This is different from simply calling any goat pneumonia contagious caprine pleuropneumonia. Correct identification matters because the differential, testing and official response can differ. Do not infer a specific agent from the word Mycoplasma on a preliminary report.
Local occurrence also matters. An international disease description is background information, not evidence that a particular herd has the infection. Veterinary investigation should connect the organism, affected tissues and group pattern.
Healthy-looking carriers are a major control problem
Animals can remain infected after clinical improvement, and some carriers have no obvious signs. Both sexes and different age groups can be involved. A group selected only because its udders look normal can therefore still introduce infection. Persistent and subclinical carrier infection.
Once present, milk-associated exposure is important for nursing young, while milking equipment and close contact can contribute to adult transmission. The useful assessment includes replacements, milk handling and animal contact rather than only the visibly sick doe.
Keep suspect groups separate while arranging advice. Review whether equipment or pooled milk connects affected and unaffected animals. An apparently convenient transfer of milk to youngstock can become an exposure pathway if the source group is infected. Milk and contact transmission context.
Diagnosis needs direct evidence as well as the clinical pattern
The veterinarian can coordinate appropriate samples from affected tissues and laboratory testing such as PCR or organism identification. The best approach depends on whether the problem is an active outbreak, an individual lesion or suspected silent infection in a chronically affected herd.
Antibody tests can be useful at group level but cannot reliably identify every carrier. A seronegative result does not guarantee that an animal is uninfected. Intermittent shedding and the choice of sampling site can also limit what one negative direct test establishes. Testing and carrier-detection limitations.
The diagnostic plan should distinguish this syndrome from other mastitis, pinkeye, septic arthritis and nutritional or management-related milk loss. Several of those problems can coexist. A clear laboratory report should specify what was detected rather than merely endorse the descriptive name “agalactia.”
Immediate care protects the dam and dependent young
A painful udder, inability to bear weight, severe eye pain, respiratory distress or systemic illness warrants prompt veterinary care. Treatment may include suitable antimicrobials and supportive or pain-relieving care, chosen for the actual clinical findings and local food-animal prescribing requirements.
An animal can improve without clearing infection. That distinction should be explicit when deciding whether to retain, breed, milk or return it to an uninfected group. A decline in visible cases is encouraging for welfare but is not proof that the herd is free. Treatment benefit and persistence.
Provide a safe feeding plan for lambs and kids whose dams have inadequate milk. Milk or colostrum management needs to preserve nutrition while limiting infection exposure; use veterinary advice for the farm’s processing and sourcing options rather than improvising a universal home protocol.
Milking hygiene and group separation need to work together
Arrange handling and milking so that affected groups do not contaminate equipment serving unaffected groups. Maintain effective equipment cleaning and assess teat and udder care. The plan must be feasible through an entire milking routine, not just during the examination of one sick animal.
Where elimination is the objective, removal or sustained segregation of infected animals may be necessary. In an endemic herd that retains infected stock, exposure reduction and continued diagnostic oversight become especially important. Neither approach should be described as instant eradication based on a single test or a short treatment course.
Purchasing decisions should consider the source herd and an appropriate testing strategy. A brief normal examination and one antibody result provide limited assurance against silent carriers. Discuss how the receiving herd’s health goal changes the level of assurance required.
Vaccines have bounded roles
Vaccines are used in some endemic settings, but effectiveness and organism coverage vary. They may reduce clinical losses without preventing infection or shedding. Product availability and authorization are local matters; a vaccine used abroad should not automatically be copied into this herd’s program. Vaccination context; Vaccine limitations.
Do not initiate vaccination during an outbreak without veterinary direction. A vaccine is not a treatment for the already painful udder or joint, nor a certificate that recovered animals can safely enter a naive flock.
Does loss of milk alone mean contagious agalactia?
No. Nutrition, other mastitis organisms and several management problems can reduce production. The syndrome requires a clinical and laboratory assessment.
Is it a common zoonotic infection?
It is not regarded as a typical zoonotic disease. That does not remove ordinary milk hygiene or animal-care precautions. The sheep and goat hubs provide related udder, youngstock and respiratory references.
Cite this reference
LivestockDefense. “Contagious agalactia in sheep and goats: milk loss, painful joints and carrier infection.” Updated 2026-11-02. https://livestockdefense.com/threats/contagious-agalactia-of-sheep-and-goats/
Add the date you accessed the page. This identifies the current reference; keep a permitted saved copy if your work depends on its exact wording. A citation alone does not establish support for a claim.
How to cite a page and its revision ↗Sources & boundaries
Read the evidence in context.
These documents support the statements identified in this reference. Check their scope and dates when deciding whether they answer your question.
- Merck Veterinary Manual: Contagious agalactia in small ruminants
Source update: 2025-12. Most recent check: 2026-11-02.
Multi-agent syndrome, persistent/seronegative carriers, direct organism testing, treatment and vaccine limitations. No mycoplasma culture, agent propagation, invasive collection or drug dose reproduced.
- Iowa State University Center for Food Security and Public Health: Contagious agalactia
Source update: 2018-10. Most recent check: 2026-11-02.
Clinical variation, milk/contact exposure and offspring disease; historical distribution and vaccine availability not treated as current local status.
- World Organisation for Animal Health: Contagious agalactia
Source update: Not provided. Most recent check: 2026-11-02.
Mastitis/arthritis/eye syndrome and organism distinctions including pneumonia-associated goat presentations. Listing not converted into a universal owner legal requirement; no unsupported common zoonotic-risk claim.
